Infective endocarditis: diagnosis, treatment and prevention An overview of the pathogenesis, diagnosis, treatment and prevention of infective endocarditis, as well as the role of the pharmacist in managing the infection.…
Discharge of bacteria from sewage into UK rivers risks antimicrobial resistance, experts warn The chief medical officer for England, and the chairs of Ofwat and the Environment Agency, have said water companies are not doing enough to prevent sewage and coliforms from escaping into UK rivers.…
SARS-CoV2 antivirals are essential, but they are not silver bullets The UK government's 'living with COVID-19' policy is relying too much on antiviral treatments, but now is not the time to relax.…
Antibiotic use in older adults linked to inflammatory bowel disease, research suggests Patients aged 60 years and over who had received five or more courses of antibiotics in five years were 2.3 times more likely to develop inflammatory bowel disease.…
Pharmacies prevented from signing up for minor ailments service over AMR concerns NHS England has paused sign-ups for the extended care service in the Midlands while it carries out a review of community pharmacy services where antibiotics are supplied without a prescription.…
Can antiviral drugs turn the tide on COVID-19? In this episode, we discuss how the novel COVID-19 oral antivirals work and answer questions about them from readers.…
Government recommends Paxlovid as first-line treatment for eligible COVID-19 patients New guidance advises that patients who test positive for COVID-19 following their admission to hospital should be offered Paxlovid (nirmatrelvir + ritonavir) first.…
Pharmacist antibiotic use doubles after sore throat testing requirement is removed Data from the Welsh community pharmacy Sore Throat Test and Treat (STTT) service show that antibiotic prescribing increased from 27% to 63% during the COVID-19 pandemic.…
Community pharmacies to supply antiviral treatments to high-risk COVID-19 patients Scottish community pharmacies will be able to dispense the antiviral molnupiravir to patients at high risk of severe illness or death from COVID-19.…
COVID-19 antiviral trial recruits more than 350 patients as community treatment is rolled out As soon as they test positive for COVID-19, eligible patients are being encouraged to sign up to the PANORAMIC study, which is investigating the effects of molnupiravir.…